144 related articles for article (PubMed ID: 10332921)
1. Vitamin E, alpha- and gamma-tocopherol, and prostate cancer.
Moyad MA; Brumfield SK; Pienta KJ
Semin Urol Oncol; 1999 May; 17(2):85-90. PubMed ID: 10332921
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E supplements and risk of prostate cancer in U.S. men.
Rodriguez C; Jacobs EJ; Mondul AM; Calle EE; McCullough ML; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):378-82. PubMed ID: 15006912
[TBL] [Abstract][Full Text] [Related]
3. Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study.
Weinstein SJ; Wright ME; Pietinen P; King I; Tan C; Taylor PR; Virtamo J; Albanes D
J Natl Cancer Inst; 2005 Mar; 97(5):396-9. PubMed ID: 15741576
[TBL] [Abstract][Full Text] [Related]
4. The modulation of prostate cancer risk with alpha-tocopherol: a pilot randomized, controlled clinical trial.
Hernáandez J; Syed S; Weiss G; Fernandes G; von Merveldt D; Troyer DA; Basler JW; Thompson IM
J Urol; 2005 Aug; 174(2):519-22. PubMed ID: 16006884
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
[TBL] [Abstract][Full Text] [Related]
6. Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer.
Kim J; Sun P; Lam YW; Troncoso P; Sabichi AL; Babaian RJ; Pisters LL; Pettaway CA; Wood CG; Lippman SM; McDonnell TJ; Lieberman R; Logothetis C; Ho SM
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1697-702. PubMed ID: 16030104
[TBL] [Abstract][Full Text] [Related]
7. Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.
Pak RW; Lanteri VJ; Scheuch JR; Sawczuk IS
Integr Cancer Ther; 2002 Dec; 1(4):338-44. PubMed ID: 14664728
[TBL] [Abstract][Full Text] [Related]
8. Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells.
Zu K; Ip C
Cancer Res; 2003 Oct; 63(20):6988-95. PubMed ID: 14583501
[TBL] [Abstract][Full Text] [Related]
9. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States.
Chan JM; Stampfer MJ; Ma J; Rimm EB; Willett WC; Giovannucci EL
Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):893-9. PubMed ID: 10548318
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect of vitamin E and selenium in human prostate cancer cell lines.
Venkateswaran V; Fleshner NE; Klotz LH
Prostate Cancer Prostatic Dis; 2004; 7(1):54-6. PubMed ID: 14745439
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluation of anticancer actions of natural and synthetic vitamin E forms.
Yu W; Jia L; Wang P; Lawson KA; Simmons-Menchaca M; Park SK; Sun L; Sanders BG; Kline K
Mol Nutr Food Res; 2008 Apr; 52(4):447-56. PubMed ID: 18381678
[TBL] [Abstract][Full Text] [Related]
12. Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA.
Anderson K; Simmons-Menchaca M; Lawson KA; Atkinson J; Sanders BG; Kline K
Cancer Res; 2004 Jun; 64(12):4263-9. PubMed ID: 15205340
[TBL] [Abstract][Full Text] [Related]
13. Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway.
Ni J; Wen X; Yao J; Chang HC; Yin Y; Zhang M; Xie S; Chen M; Simons B; Chang P; di Sant'Agnese A; Messing EM; Yeh S
Cancer Res; 2005 Nov; 65(21):9807-16. PubMed ID: 16267002
[TBL] [Abstract][Full Text] [Related]
14. The effects of supplementation with alpha-tocopherol and beta-carotene on the incidence and mortality of carcinoma of the pancreas in a randomized, controlled trial.
Rautalahti MT; Virtamo JR; Taylor PR; Heinonen OP; Albanes D; Haukka JK; Edwards BK; Kärkkäinen PA; Stolzenberg-Solomon RZ; Huttunen J
Cancer; 1999 Jul; 86(1):37-42. PubMed ID: 10391561
[TBL] [Abstract][Full Text] [Related]
15. Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer.
Hahn T; Szabo L; Gold M; Ramanathapuram L; Hurley LH; Akporiaye ET
Cancer Res; 2006 Oct; 66(19):9374-8. PubMed ID: 17018590
[TBL] [Abstract][Full Text] [Related]
16. The roles of alpha-vitamin E and its analogues in prostate cancer.
Ni J; Yeh S
Vitam Horm; 2007; 76():493-518. PubMed ID: 17628187
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort.
Peters U; Littman AJ; Kristal AR; Patterson RE; Potter JD; White E
Cancer Causes Control; 2008 Feb; 19(1):75-87. PubMed ID: 17943452
[TBL] [Abstract][Full Text] [Related]
18. The effect of vitamin E on blood pressure in individuals with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Ward NC; Wu JH; Clarke MW; Puddey IB; Burke V; Croft KD; Hodgson JM
J Hypertens; 2007 Jan; 25(1):227-34. PubMed ID: 17143195
[TBL] [Abstract][Full Text] [Related]
19. The effect of alpha- and gamma-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation.
Galli F; Stabile AM; Betti M; Conte C; Pistilli A; Rende M; Floridi A; Azzi A
Arch Biochem Biophys; 2004 Mar; 423(1):97-102. PubMed ID: 14871472
[TBL] [Abstract][Full Text] [Related]
20. Update on prostate cancer chemoprevention.
Lowe JF; Frazee LA
Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
